Table 3.
Immunostaining results of other markers studied.
| ECA | EMMA | p-value | ||
| ER | Score 0–3 | 11/14 (79%) | 1/18 (6%) | <0.001 |
| Score 4–12 | 3/14 (21%) | 17/18 (94%) | ||
| Median (Range) | 0 (0–12) | 7.5 (2–12) | <0.001 | |
| PR | Score 0–3 | 11/14 (79%) | 2/18 (11%) | <0.001 |
| Score 4–12 | 3/14 (21%) | 16/18 (89%) | ||
| Median (Range) | 0 (0–12) | 9 (1–12) | <0.001 | |
| Vim | Score 0–3 | 13/14 (93%) | 9/18 (50%) | 0.01 |
| Score 4–12 | 1/14 (7%) | 9/18 (50%) | ||
| Median (Range) | 0 (0–2) | 1.5 (0–9) | 0.002 |
ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma; NS, not significant.